Clinical Trial Update: Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901 [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on pharmacokinetics, efficacy, and safety of recombinant and protein-free Factor VIII (rAHF-PFM) in Hemophilia A patients; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rAHF-PFM (recombinant and protein-free Factor VIII) (recombinant and protein-free Factor VIII)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 2, Phase 3 | Status: COMPLETED